Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2

• 主要な著者: Shi-Bing Zhang (著者), Ming Hong (著者), Xiao-Yang Sun (著者), Da Huang (著者), Dan-Hua He (著者), Yu-Fei Chen (著者), Yong Yuan (著者), Yong-Qiang Liu (著者)
• フォーマット: 図書
• 出版事項: Compuscript Ltd, 2022-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Silybin (SB), a natural flavonoid isolated from Silybum marianum, has been used to treat hepatic fibrosis in clinical settings and as a dietary supplement, because of its hepatoprotective potential. Numerous studies have shown that SB also exerts promising anticancer effects; however, the anticancer...